STOCK TITAN

iRhythm Technologies, Inc - IRTC STOCK NEWS

Welcome to our dedicated news page for iRhythm Technologies (Ticker: IRTC), a resource for investors and traders seeking the latest updates and insights on iRhythm Technologies.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect iRhythm Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of iRhythm Technologies's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.56%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.77%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.77%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.59%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
32.63%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.95%
Tags
covid-19
iRhythm Technologies, Inc

Nasdaq:IRTC

IRTC Rankings

IRTC Stock Data

3.48B
30.66M
1.05%
109.1%
8.24%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
San Francisco

About IRTC

irhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ecg, monitoring for patients at risk for arrhythmias. we have created a unique platform, zio by irhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.